Parkinson's Disease Clinical Trials

Showing 1441-1460 of 1,818 trials

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

NCT00143026

This study examines the effect of treatment of levodopa/entacapone on quality of life, as measured by the Parkinson's Disease-Questionnaire 8 (PDQ-8), in Parkinson's disease patients with no or minimal, non-disabling motor fluctuations.

Parkinson's Disease

Novartis184 participantsStarted Jul 2005

Adelaide, Australia • Brisbane, Australia • Gosford, Australia +15 more locations

COMPLETEDPhase 1

Tolerability and Steady-state Pharmacokinetics of BIA 6-512

NCT03093389

To investigate the tolerability and safety of four multiple-dose regimens of BIA 6-512 (25 mg, 50 mg, 100 mg, and 150 mg 6 times daily) in healthy volunteers and to characterise the steady-state pharmacokinetic profiles of BIA 6-512 (25 mg, 50 mg, 100 mg, and 150 mg 6 times daily) in healthy volunteers.

Parkinson Disease

Bial - Portela C S.A.40 participantsStarted May 2005

S. Mamede Do Coronado, Portugal

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

Tolerability and Steady-state Pharmacokinetics of BIA 6-512

Related Searches

Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease

An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease

Caffeine as a Therapy for Parkinson's Disease

A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease

Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease

Parkinsonics: A Controlled Study of Group Singing in Parkinson Disease

Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

Remote Access to Care, Everywhere, for Parkinson Disease

Effect of Levodopa on Postural Motor Learning in Parkinson Disease

Transcutaneous Electric Nerve Stimulation in Sleep of Patients With Parkinson's Disease

Virtual Reality in Parkinson Disease

Expiratory Muscle Training for Persons With Neurodegenerative Disease

Erythromycin in Parkinson's Disease

Computerized Cognitive Behavioral Therapy Trial for Insomnia in Parkinson Disease

Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation